Global Natural Killer Cell Therapy Competitive Landscape Professional Research Report 2024

Global Natural Killer Cell Therapy Competitive Landscape Professional Research Report 2024

Research Summary

Natural killer (NK) cell therapy is a form of immunotherapy that utilizes a patient’s own or donor-derived NK cells to treat various diseases, particularly cancer. NK cells are a type of white blood cell that plays a critical role in the body’s innate immune response, specifically targeting and eliminating abnormal or infected cells. In NK cell therapy, these cells are isolated, expanded, and sometimes genetically modified in the lab before being infused back into the patient. The goal is to enhance the activity and effectiveness of NK cells in recognizing and killing cancer cells. NK cell therapy has shown promise in treating several types of cancers, including leukemia, lymphoma, and solid tumors. The therapy can be used alone or in combination with other treatments such as chemotherapy or checkpoint inhibitors. It offers the potential for targeted and personalized cancer treatment with potentially fewer side effects than traditional treatments. Ongoing research and clinical trials are exploring the optimal techniques for producing and administering NK cell therapy to improve patient outcomes and expand its application in the field of cancer immunotherapy.

According to DIResearch's in-depth investigation and research, the global Natural Killer Cell Therapy market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Natural Killer Cell Therapy include Nektar Therapeutics, Innate Pharma, Affimed, Chipscreen Biosciences, Glycostem Therapeutics, Fate Therapeutics, Dragonfly Therapeutics, Nkarta Therapeutics, Kiadis Pharma, NantKwest etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Natural Killer Cell Therapy. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Natural Killer Cell Therapy market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Natural Killer Cell Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Natural Killer Cell Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Natural Killer Cell Therapy Include:

Nektar Therapeutics

Innate Pharma

Affimed

Chipscreen Biosciences

Glycostem Therapeutics

Fate Therapeutics

Dragonfly Therapeutics

Nkarta Therapeutics

Kiadis Pharma

NantKwest

Natural Killer Cell Therapy Product Segment Include:

NK Cell Therapies

NK Cell Directed Antibodies

Natural Killer Cell Therapy Product Application Include:

Cancer

Gastrointestinal Diseases

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Natural Killer Cell Therapy Industry PESTEL Analysis

Chapter 3: Global Natural Killer Cell Therapy Industry Porter’s Five Forces Analysis

Chapter 4: Global Natural Killer Cell Therapy Major Regional Market Size and Forecast Analysis

Chapter 5: Global Natural Killer Cell Therapy Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Natural Killer Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Natural Killer Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Natural Killer Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Natural Killer Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Natural Killer Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Natural Killer Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Natural Killer Cell Therapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources